Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3213_Библиотеки_им_академика_М_И_Перельмана
.pdf
Источник KingMed.info
341
Douros A., Bronder E., Andersohn F. et al. Flupirtine-induced liver injury - seven cases from the Berlin
case-control surveillance study and review of the German spontaneous adverse drug reaction reporting
database // Eur. J. Clin. Pharmacol. 2014.
Vol. 70, N. 4. P. 453-459.
Douros A., Renoux C., Yin H. et al. Concomitant use of direct oral anticoagulants with antiplatelet
agents and the risk of major bleeding in patients with nonvalvular atrial fibrillation // Am. J. Med. 2019.
Vol. 2. P. 191-199.e12.
Douxfils J., Buckinx F., Mullier F. et al. Dabigatran etexilate and risk of myocar-dial infarction, other
cardiovascular events, major bleeding, and all-cause mortality: a systematic review and meta-analysis
of RCI // J. Am. Heart Assoc. 2014. Vol. 3, N. 3.
Article ID e000515.
Draper K.V., Huang R.J., Gerson L.B. GI bleeding in patients with continuous-flow left ventricular assist
devices: a systematic review and meta-analysis // Gastrointest.
Endosc. 2014. Vol. 80, N. 3. P. 435-446.e1.
Drawz P.E., Alper A.B., Anderson A.H. et al. Masked hypertension and elevated nighttime blood
pressure in CKD: prevalence and association with target organ damage // Clin. J. Am. Soc. Nephrol.
2016. Vol. 11, N. 4. P. 642-652.
Dubois S., Bedard M., Weaver B. The impact of benzodiazepines on safe driving // Traffic Inj. Prev. 2008.
Vol. 9, N. 5. P. 404-413.
Dunlay S.M., Weston S.A., Killian J.M. et al. Thirty-day rehospitalizations after acute myocardial
infarction: a cohort study // Ann. Intern. Med. 2012. Vol. 157, N. 1.
P. 11-18.
Echouffo-Tcheugui J.B., Masoudi F.A. et al. Diabetes mellitus and outcomes of cardiac
resynchronization with implantable cardioverter-defibrillator therapy in older patients with heart failure
// Circ. Arrhythm. Electrophysiol. 2016. Vol. 9, N. 8. Article
ID e004132.
Eddy D.M., Adler J., Patterson B. et al. Individualized guidelines: the potential for increasing quality and
reducing costs // Ann. Intern. Med. 2011. Vol. 154, N. 9.
P. 627-634.
Edmondstone W.M. Chest pain and non-respiratory symptoms in acute asthma //
Postgrad. Med. J. 2000. Vol. 76, N. 897. P. 413-414.
Egbuonu F., Antonio F.A., Edavalath M. Effect of inhaled corticosteroids on glyce-
mic status // Open Respir. Med. J. 2014. Vol. 8. P. 101-105.
Eguale T., Buckeridge D.L., Winslade N.E. et al. Drug, patient, and physician characteristics associated
with off-label prescribing in primary care off-label prescribing in
primary care // Arch. Intern. Med. 2012. Vol. 172, N. 10. P. 781-788.
Источник KingMed.info
342
Eguchi K., Kabutoya T., Hoshide S., Ishikawa S. et al. Add-on use of eplerenone is effective for lowering
home and ambulatory blood pressure in drug-resistant hypertension // J. Clin. Hypertens. 2016. Vol. 18,
N. 12. P. 1250-1257.
Ekman E., Hägg S., Sundström A., Werkström V. Antihypertensive drugs and erectile dysfunction as
seen in spontaneous reports, with focus on angiotensin II type 1 receptor blockers // Drug Healthc.
Patient Saf. 2010. Vol. 2. P. 21-25.
Ekström M.P., Hermansson A.B., Strom K.E. Effects of cardiovascular drugs on mortality in severe
chronic obstructive pulmonary disease // Am. J. Respir. Crit. Care
Med. 2013. Vol. 187, N. 7. P. 715-720.
Ekström M.P., Wagner P., Strom K.E. Trends in cause-specific mortality in oxygen-dependent chronic
obstructive pulmonary disease // Am. J. Respir. Crit. Care Med.
2011. Vol. 183, N. 8. P. 1032-1036.
El Marroun H., Jaddoe V.V., Hudziak J.J. et al. Maternal use of selective serotonin reuptake inhibitors,
fetal growth, and risk of adverse birth outcomes // Arch.
Gen. Psychiatry. 2012. Vol. 69, N. 7. P. 706-714.
Elder D.H., Wei L., Szwejkowski B.R. et al. The impact of renin-angiotensin-aldosterone system blockade
on heart failure outcomes and mortality in patients identified to
have aortic regurgitation: a // J. Am. Coll. Cardiol. 2011. Vol. 58, N. 20. P. 2084-2891.
Elliott W.J., Meyer P.M. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-
analysis // Lancet. 2007. Vol. 369. P. 201-207.
Emdin C.A., Anderson S.G., Callender T. et al. Usual blood pressure, peripheral arterial disease, and
vascular risk: cohort study of 4.2 million adults // BMJ. 2015. Vol. 351. Article ID h4865.
Emdin C.A., Callender T., Cao J., Rahimi K. Effect of antihypertensive agents on risk of atrial fibrillation: a
meta-analysis of large-scale randomized trials // Europace.
2015. Vol. 17. P. 701-710.
Engoren M., Schwann T.A., Arslanian-Engoren C. et al. U-shape association between hemoglobin A1c
and late mortality in patients with heart failure after cardiac
surgery // Am. J. Cardiol. 2013. Vol. 111, N. 8. P. 1209-1213.
Ensrud K.E., Parimi N., Fink H.A. et al. Estimated GFR and risk of hip fracture in older men: comparison
of associations using cystatin C and creatinine // Am. J. Kidney
Dis. 2014. Vol. 63, N. 1. P. 31-39.
Erichsen R., Froslev T., Lash T.L. et al. Long-term statin use and the risk of gallstone disease:
apopulation-based case-control study // Am. J. Epidemiol. 2011.
Vol. 173, N. 2. P. 162-170.
Erküner Ö., Dudink E., Nieuwlaat R. et al. Effect of systemic hypertension with versus without left
ventricular hypertrophy on the progression of atrial fibrillation (from the Euro Heart Survey) // Am. J.
Cardiol. 2018. Vol. 122, N. 4. P. 578-583.
Источник KingMed.info
343
Ettehad D., Emdin C.A., Kiran A. et al. Blood pressure lowering for prevention of cardiovascular disease
and death: a systematic review and meta-analysis // Lancet.
2016. Vol. 387. P. 957-967.
Eudy A., Siega-Riz A., Engel S. et al. Effect of pregnancy on disease flares in patients with systemic lupus
erythematosus // Ann. Rheum. Dis. 2018. Vol. 6. P. 855-860.
Eurich D., Marrie T., Minhas-Sandhu J., Majumdar S. Risk of heart failure after community acquired
pneumonia: prospective controlled study with 10 years of follow-up // BMJ. 2017. Vol. 356. Article ID
j413.
Evans M., Carrero J., Szummer K. et al. Angiotensin-converting enzyme inhibitors and angiotensin
receptor blockers in myocardial infarction patients with renal dysfunction // J. Am. Coll. Cardiol. 2016.
Vol. 67, N. 14. P. 1687-1697.
Evranos B., Canpolat U., Kocyigit D. et al. Role of adjuvant renal sympathetic denervation in the
treatment of ventricular arrhythmias // Am. J. Cardiol. 2016.
Vol. 118, N. 8. P. 1207-1210.
Ewald N., Kaufmann C., Raspe A. et al. Prevalence of diabetes mellitus secondary to pancreatic diseases
(type 3c) // Diabetes Metab. Res. Rev. 2012. Vol. 28, N. 4.
P. 338-342.
Fagard R.H., Celis H., Thijs L., Wouters S. Regression of left ventricular mass by antihypertensive
treatment: a meta-analysis of randomized comparative studies //
Hypertension. 2009. Vol. 54, N. 5. P. 1084-1091.
Farland M.Z., Peters C.J., Williams J.D. et al. Beta-blocker use and incidence of chronic obstructive
pulmonary disease exacerbations // Ann. Pharmacother. 2013.
Vol. 47, N. 5. P. 651-656.
Fauchier L., Clementy N., Babuty D. Statin therapy and atrial fibrillation: systematic review and updated
meta-analysis of published randomized controlled trials // Curr. Opin. Cardiol. 2013. Vol. 28, N. 1. P. 7-
18.
Fawzy A., Putcha N., Aaron C. et al. Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-
Matched Analysis in Subpopulations and Intermediate Outcome Measures in COPD Study // CHEST.
2019. Vol. 3. P. 519-527.
Feng Y., Yang H. Metformin - a potentially effective drug for gestational diabetes mellitus: a systematic
review and meta-analysis // J. Matern. Fetal Neonatal Med.
2016. Vol. 30, N. 15. P. 1874-1881.
Ference B.A., Robinson J.G., Brook R.D. et al. Variation in PCSK9 and HMGCR and risk of cardiovascular
disease and diabetes // N. Engl. J. Med. 2016. Vol. 375, N. 22. P. 2144-2153.
Ferrannini E., Veltkamp S.A., Smulders R.A., Kadokura T. Impact of chronic kidney disease sodium-
glucose cotransporter 2 inhibition in patients with type 2 diabetes //
Diabetes Care. 2013. Vol. 36, N. 5. P. 1260-1265.
Источник KingMed.info
344
Ferri C., Sebastiani M., Antonelli A. et al. Current treatment of hepatitis C-associated rheumatic diseases
// Arthritis Res. Ther. 2012. Vol. 14, N. 3. P. 215.
Fink H.A., MacDonald R., Rutks I.R. et al. Trazodone for erectile dysfunction: a systematic review and
meta-analysis // BJU Int. 2003. Vol. 92, N. 4. P. 441-446.
Flynn R., MacDonald T., Murray G. et al. Prescribing antiplatelet medicine and subsequent events after
intracerebral hemorrhage // Stroke. 2010. Vol. 11. P. 2606-2611.
Fogari R., Mugellini A., Destro M. et al. Losartan and prevention of atrial fibrillation recurrence in
hypertensive patients // J. Cardiovasc. Pharmacol. 2006. Vol. 47.
P. 46-50.
Fokkema M.L., van der Meer P., Rao S.V. et al. Safety and clinical outcome of erythropoiesis-stimulating
agents in patients with ST-elevation myocardial infarction: a meta-analysis of individual patient data //
Am. Heart J. 2014. Vol. 168. P. 354-362.e2.
Fortin M., Lapointe L., Hudon C. et al. Multimorbidity and quality of life in primary care: a systematic
review // Health Qual. Life Outcomes. 2004. Vol. 2. P. 51.
Fosbol E.L., Wang T.Y., Li S. et al. Warfarin use among older atrial fibrillation patients with non-ST-
segment elevation myocardial infarction managed with coronary stenting dual antiplatelet therapy //
Am. Heart J. 2013. Vol. 166, N. 5. P. 864-870.
Fournier J., Azoulay L., Yin H. et al. Tramadol use and the risk of hospitaliza-tion for hypoglycemia in
patients with noncancer pain // JAMA Intern. Med. 2015.
Vol. 175, N. 2. P. 186-193.
Fournier J.-P., Yin H., Nessim S.J. et al. Tramadol for noncancer pain and the risk of hyponatremia // Am.
J. Med. 2015. Vol. 128. P. 418-425.e5.
Friedland S.N., Eisenberg M.J., Shimony A. Meta-analysis of randomized controlled trials on effect of
cilostazol on restenosis rates and outcomes after percutaneous coronary intervention // Am. J. Cardiol.
2012. Vol. 109, N. 10. P. 1397-1404.
Funk K.A., Bostwick J.R. A comparison of the risk of QT prolongation among SSRIs // Ann.
Pharmacother. 2013. Vol. 47, N. 10. P. 1330-1341.
Furberg C.D., Psaty B.M., Meyer J.V. Nifedipine. Dose-related increase in mortality in patients with
coronary heart disease // Circulation. 1995. Vol. 92, N. 5.
P. 1326-1331.
Fuster D., Samet J. Alcohol use in patients with chronic liver disease // N. Engl. J.
Med. 2018. Vol. 13. P. 1251-1261.
Gade E.J., Thomsen S.F., Lindenberg S., Backer V. Fertility outcomes in asthma: a clinical study of 245
women with unexplained infertility // Eur. Respir. J. 2016. Vol. 47,
N. 4. P. 1144-1151.
Gallagher C., Hendriks J.M.L., Elliott A.D. et al. Alcohol and incident atrial fibrillation - a systematic
review and meta-analysis // Int. J. Cardiol. 2017. Vol. 246.
P. 46-52.
Источник KingMed.info
345
Gallwitz B., Rosenstock J., Rauch T. et al. 2-year efficacy and safety of linagliptin compared with
glimepiride in patients with type 2 diabetes inadequately controlled on
metformin // Lancet. 2012. Vol. 380. P. 475-483.
Gandhi S., Fleet J.L., Bailey D.G. et al. Calcium-channel blocker-clarithromycin drug interactions and
acute kidney injury // JAMA. 2013. Vol. 310, N. 23. P. 2544-2553.
Gangopadhyay K.K., Singh P. Consensus statement on dose modifications of anti-diabetic agents in
patients with hepatic impairment // Indian J. Endocrinol. Metab. 2017. Vol. 21, N. 2. P. 341-354.
Garcia-Aymerich J., Hernandez C., Alonso A. et al. Effects of an integrated care intervention on risk
factors of COPD readmission // Respir. Med. 2007. Vol. 101, N. 7.
P. 1462-1469.
Garg N., Thomas G., Jackson G. et al. Cardiac resynchronization therapy in CKD: asystematic review //
Clin. J. Am. Soc. Nephrol. 2013. Vol. 8, N. 8. P. 1293-303.
Gastelurrutia P., Lupon J., de Antonio M. et al. Statins in heart failure: the paradox between large
randomized clinical trials and real life // Mayo Clin. Proc. 2012. Vol. 87,
N. 6. P. 555-560.
Gathier C., van den Bergh W., van der Jagt M. et al. Induced hypertension for delayed cerebral ischemia
after aneurysmal subarachnoid hemorrhage // Stroke. 2018.
Vol. 1. P. 76-83.
Gencer B., Collet T.H., Virgini V. et al. Subclinical thyroid dysfunction and the risk of heart failure events
// Circulation. 2012. Vol. 126, N. 9. P. 1040-1049.
Geng D., Jin D., Wu W. et al. Angiotensin converting enzyme inhibitors for prevention of new-onset
type 2 diabetes mellitus: a meta-analysis of 72,128 patients // Int. J.
Cardiol. 2013. Vol. 6. P. 2605-2610.
Geng D.F., Jin D.M., Wu W. et al. Angiotensin receptor blockers for prevention of new-onset type 2
diabetes: a meta-analysis of 59 862 patients // Int. J. Cardiol. 2012.
Vol. 155, N. 2. P. 236-242.
Geng Q., Ren J., Song J., Li S. et al. Meta-analysis of the effect of statins on renal function // Am. J.
Cardiol. 2014. Vol. 114. P. 562-570.
Genoni M., Paul M., Jenni R. et al. Chronic beta-blocker therapy improves outcome and reduces
treatment costs in chronic type B aortic dissection // Eur. J.
Cardiothorac. Surg. 2001. Vol. 19, N. 5. P. 606-610.
Gencer B, Collet TH, Virgini V, et al. Subclinical Thyroid Dysfunction and the Risk of Heart Failure Events.
Circulation 2012;126(9):1040-9.
Gerber Y., Melton L.J., McNallan S.M. et al. Cardiovascular and noncardiovascu-lardisease associations
with hip fractures // Am. J. Med. 2013. Vol. 126, N. 2. P. 169.
Gershon A.S., Campitelli M.A., Hawken S. et al. Cardiovascular and neuropsychi-atric events following
varenicline use for smoking cessation // Am. J. Respir. Crit. Care
Источник KingMed.info
346
Med. 2018. Vol. 197, N. 7. P. 913-922.
Gheorghiade M., Abraham W.T., Albert N.M. et al. Systolic blood pressure at admission, clinical
characteristics, and outcomes in patients hospitalized with acute
heart failure // JAMA. 2006. Vol. 296. P. 2217-2226.
Ghulmiyyah L.M., Alame M.M., Mirza F.G. et al. Influenza and its treatment during pregnancy: a review
// J. Neonatal. Perinatal. Med. 2016. Vol. 8, N. 4. P. 297-
306.
Gislason GH, Rasmussen JN, Abildstrom SZ, et al. Increased Mortality and Cardiovascular Morbidity
Associated With Use of Nonsteroidal Anti-inflammatory
Drugs in Chronic Heart Failure. Arch Intern Med 2009;169(2):141-9.
Girodet P.-O., Dournes G., Thumerel M. et al. Calcium channel blocker reduces airway remodeling in
severe asthma. A proof-of-concept study // Am. J. Respir. Crit.
Care. Med. 2015. Vol. 191. P. 876-883.
Gjestad C., Westin A.A., Skogvoll E., Spigset O. Effect of proton pump inhibitors on the serum
concentrations of the selective serotonin reuptake inhibitors citalopram, escitalopram, and sertraline //
Ther. Drug Monit. 2015. Vol. 37, N. 1. P. 90-97.
Go A.S., Singer D.E., Toh S. et al. Outcomes of dabigatran and warfarin for atrial fibrillation in
contemporary practice: a retrospective cohort study // Ann. Intern. Med.
2017. Vol. 167, N. 12. P. 845-854.
Godfrey L.M., Erramouspe J., Cleveland K.W. Teratogenic risk of statins in pregnancy // Ann.
Pharmacother. 2012. Vol. 46, N. 10. P. 1419-1424.
Goel K., Pinto D.S., Gibson C.M. Association of time to reperfusion with left ventricular function and
heart failure in patients with acute myocardial infarction treated with primary PCI // Am. Heart J. 2013.
Vol. 165. P. 451-467.
Goh S.S.-N., Sia C.-H., Ngiam N.J. et al. Effect of renin-angiotensin blockers on left ventricular
remodeling in severe aortic stenosis // Am. J. Cardiol. 2017. Vol. 119,
N. 11. P. 1839-1845.
Göksülük H., Güleç S., Özyüncü N. et al. Comparison of frequency of silent cerebral infarction after
coronary angiography and stenting with transradial versus trans-
femoral approaches // Am. J. Cardiol. 2018. Vol. 4. P. 548-553.
Goldberg O., Moretti M., Levy A. et al. Exposure to nitrofurantoin during early pregnancy and
congenital malformations: a systematic review and meta-analysis //
J. Obstet. Gynaecol Can. 2015. Vol. 37, N. 2. P. 150-156.
Goldstein J.N., Fazen L.E., Wendell L. et al. Risk of thromboembolism following acute intracerebral
hemorrhage // Neurocrit. Care. 2009. Vol. 10, N. 1. P. 28-34.
Golomb B.A., Evans M.A., Dimsdale J.E., White H.L. Effects of statins on energy and fatigue with
exertion: results from a randomized controlled trial // Arch.
Источник KingMed.info
347
Intern. Med. 2012. Vol. 172, N. 15. P. 1180-1182.
Gonzalez A., Kremers H.M., Crowson C.S. et al. Do cardiovascular risk factors confer the same risk for
cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? //
Ann. Rheum. Dis. 2008. Vol. 67. P. 64-69.
Gorostidi M., Sarafidis P.A., de la Sierra A. et al. Differences between office and 24-hour blood pressure
control in hypertensive patients with CKD // Am. J. Kidney
Dis. 2013. Vol. 62, N. 2. P. 285-294.
Goto A., Arah O.A., Goto M. et al. Severe hypoglycaemia and cardiovascular disease: systematic review
and meta-analysis with bias analysis // BMJ. 2013. Vol. 347.
Article ID f4533.
Graipe A., Söderström L., Mooe T. et al. Increased use of ticagrelor after myocar-dial infarction is not
associated with intracranial hemorrhage // Stroke. 2018. Vol. 12.
P. 2877-2882.
Graner S., Svensson T., Beau A.-B. et al. Neuraminidase inhibitors during pregnancy and risk of adverse
neonatal outcomes and congenital malformations: population based European register study // BMJ.
2017. Vol. 356. Article ID j629.
Gransbo K., Melander O., Wallentin L. et al. Cardiovascular and cancer mortality in very elderly post-
myocardial infarction patients receiving statin treatment // J. Am.
Coll. Cardiol. 2010. Vol. 55, N. 13. P. 1362-1369.
Grimaldi-Bensouda L., Alpérovitch A., Aubrun E. et al. Impact of allopurinol on risk of myocardial
infarction // Ann. Rheum. Dis. 2015. Vol. 74. P. 836-842.
Groh C., Faulkner M., Getabecha S., et al. Patient-reported triggers of paroxysmal atrial fibrillation.
Heart Rhythm. 2019.
Grymonprez M., Vakaet V., Kavousi M. et al. Chronic obstructive pulmonary disease and the
development of atrial fibrillation // Int. J. Cardiol. 2019. Vol. 276.
P. 118-124.
Guedes M., Esperança A., Pereira A.C., Rego C. What is the effect on cardiovascular events of reducing
hyperuricemia with allopurinol? An evidence-based review //
Rev. Port. Cardiol. 2014. Vol. 33. P. 727-732.
Guha A., Vei-Vei L., MacArthur A.E. et al. Shortand long-term outcomes of coronary artery bypass
grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with CKD
// Am. J. Cardiol. 2010. Vol. 106. P. 348-353.
Gulmez S.E., Lassen A.T., Aalykke C. et al. Spironolactone use and the risk of upper gastrointestinal
bleeding: a population-based case-control study // Br. J. Clin.
Pharmacol. 2008. Vol. 66, N. 2. P. 294-299.
Gunderson E.P., Hurston S.R., Ning X. et al. Lactation and progression to type 2 diabetes mellitus after
gestational diabetes mellitus: aprospective cohort study //
Ann. Intern. Med. 2015. Vol. 163. P. 889-898.
Источник KingMed.info
348
Guo C.-G., Chen L., Chan E.W. et al. Systematic review with meta-analysis: the risk of gastrointestinal
bleeding in patients taking third-generation P2Y12 inhibitors compared with clopidogrel // Aliment.
Pharmacol. Ther. 2019. Vol. 49. P. 7-19.
Haegens N.M., Gathier C.S., Horn J. et al. Induced hypertension in preventing cerebral infarction in
delayed cerebral ischemia after subarachnoid hemorrhage //
Stroke. 2018. Vol. 11. P. 2630-2636.
Hage F.G., Lusa L., Dondi M. et al. Exercise stress tests for detecting myocar-dial ischemia in
asymptomatic patients with diabetes mellitus // Am. J. Cardiol. 2013.
Vol. 112, N. 1. P. 14-20.
Hage M.P., Al-Badri M.R., Azar S.T. A favorable effect of hydroxychloroquine on glucose and lipid
metabolism beyond its anti-inflammatory role // Ther. Adv.
Endocrinol. Metab. 2014. Vol. 5. P. 77-85.
Hamed A.E., Elsahar M., Elwan N.M. et al. Managing diabetes and liver disease association // Arab. J.
Gastroenterol. 2018. Vol. 19, N. 4. P. 166-179.
Hanefeld M., Cagatay M., Petrowitsch T. et al. Acarbose reduces the risk for myocardial infarction in
type 2 diabetic patients: meta-analysis of seven long-term
studies // Eur. Heart J. 2004. Vol. 25, N. 1. P. 10-16.
Haney E.M., Chan B.K.S., Diem S.J. et al. Association of low bone mineral density with selective
serotonin reuptake inhibitor use by older men // Arch. Intern. Med. 2007.
Vol. 167. P. 1246-1251.
Hansen M.L., Sorensen R., Clausen M.T. et al. Risk of bleeding with single, dual, or triple therapy with
warfarin, aspirin, and clopidogrel in patients with atrial fibrillation // Arch. Intern. Med. 2010. Vol. 170,
N. 16. P. 1433-1441.
Hande K.R., Noone R.M., Stone W.J. et al. Severe allopurinol toxicity. Description and guidelines for
prevention in patients with renal insufficiency // Am. J. Med. 1984.
Vol. 76, N. 1. P. 47-56.
Hao Q., Tampi M., O'Donnell M. et al. Clopidogrel plus aspirin versus aspirin alone for acute minor
ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis // BMJ.
2018. Vol. 363. Article ID k5108.
Hara M., Sakata Y., Nakatani D. et al. Comparison of 5-year survival after acute myocardial infarction
using angiotensin-converting enzyme inhibitor versus angiotensin II receptor blocker // Am. J. Cardiol.
2014. Vol. 114. P. 1-8.
Harer K.N., Enders F.T., Lim K.G. et al. An allergic phenotype and the use of steroid inhalers predict
eosinophilic oesophagitis in patients with asthma // Aliment.
Pharmacol. Ther. 2013. Vol. 37, N. 1. P. 107-113.
Harold L.D., Deepak L.B., Daniel D.G. et al. Bridging the gap between clinical trials of antiplatelet
therapies and applications among elderly patients // Am. Heart J.
2010. Vol. 159, N. 4. P. 508-517.
Источник KingMed.info
349
Hassan G., Qureshi W., Khan G.Q., Asmi R. Cardiovascular consequences of fiberoptic bronchoscopy //
JK Science. 2005. Vol. 7. P. 1-2.
Hastie C.E., Padmanabhan S., Slack R. et al. Obesity paradox in a cohort of 4880 consecutive patients
undergoing percutaneous coronary intervention // Eur. Heart J.
2010. Vol. 31, N. 2. P. 222-226.
Hawkins N.M., Petrie M.C., Jhund P.S. et al. Heart failure and chronic obstructive pulmonary disease:
diagnostic pitfalls and epidemiology // Eur. J. Heart Fail. 2009.
Vol. 11. P. 130-139.
Hawwa N., Menon V. Ranolazine: clinical applications and therapeutic basis // Am
J. Cardiovasc. Drugs. 2013. Vol. 13. P. 5-16.
Hedner J., Everts B., Möller C.S. Latanoprost and respiratory function in asthmatic patients: randomized,
double-masked, placebo-controlled crossover evaluation //
Arch. Ophthalmol. 1999. Vol. 117, N. 10. P. 1305-1309.
Henderson J.T., Whitlock E.P., O'Connor E. et al. Low-dose aspirin for prevention of morbidity and
mortality from preeclampsia: asystematic evidence review for the U.S. Preventive Services Task Force //
Ann. Intern. Med. 2014. Vol. 160. P. 695-703.
Hendrie H.C., Lindgren D., Hay D.P. et al. Comorbidity profile and healthcare utilization in elderly
patients with serious mental illnesses // Am. J. Geriatr. Psychiatry.
2013. Vol. 21, N. 12. P. 1267-1276.
Herrin M.A., Feemster L., Crothers K. et al. Combination antihypertensive therapy
among patients with COPD // Chest. 2013. Vol. 143, N. 5. P. 1312-1320.
Herzog C.A., Solid C. Survival of Dialysis Patients in the US after surgical versus percutaneous coronary
intervention // Kidney Week. 2012. San Diego, CA, November 3, 2012. Abstract HI-OR05.
Hirsch S., Hirsch J., Bhatt U., Rovin B.H. Tolerating increases in the serum crea-tinine following
aggressive treatment of chronic kidney disease, hypertension and proteinuria: pre-renal success // Am.
J. Nephrol. 2012. Vol. 36. P. 430-437.
Hitchings A.W., Lai D., Jones P.W. et al. Metformin in severe exacerbations of chronic obstructive
pulmonary disease: a randomised controlled trial // Thorax. 2016.
Vol. 71, N. 7. P. 587-593.
Ho K.M., Sheridan D.J. Meta-analysis of frusemide to prevent or treat acute renal
failure // BMJ. 2006. Vol. 333. P. 420-423.
Hobl E., Stimpfl T., Ebner J. et al. Morphine decreases clopidogrel concentrations and effects:
arandomized, double-blind, placebo-controlled trial // J. Am. Coll. Cardiol. 2014. Vol. 63, N. 7. P. 630-
635.
Hodge M., McArthur E., Garg A.X., Tangri N. et al. Hypoglycemia incidence in older adults by estimated
GFR // Am. J. Kidney Dis. 2017. Vol. 70, N. 1. P. 59-68.
Источник KingMed.info
350
Hoebers L.P., Claessen B.E., Elias J. et al. Meta-analysis on the impact of percutaneous coronary
intervention of chronic total occlusions on left ventricular function and
clinical outcome // Int. J. Cardiol. 2015. Vol. 187. P. 90-96.
Höke U., Khidir M.J.H., van der Velde E.T. et al. Cardiac resynchronization therapy in CKD stage 4
patients // Clin. J. Am. Soc. Nephrol. 2015. Vol. 10. P. 1740-1748.
Hollingsworth J.M., Canales B.K., Rogers M.A.M. et al. Alpha blockers for treatment of ureteric stones:
systematic review and meta-analysis // BMJ. 2016. Vol. 355. Article ID i6112.
Holroyd E.W., Sirker A., Kwok C.S. et al. The relationship of body mass index to percutaneous coronary
intervention outcomes: does the obesity paradox exist in contemporary percutaneous coronary // JACC
Cardiovasc. Interv. 2017. Vol. 10, N. 13.
P. 1283-1292.
Hsu C.H., Hu H.Y., Huang N. et al. Early eradication has a lower risk of peptic ulcer bleeding in
Helicobacter pylori-infected chronic kidney disease patients // Eur. J.
Intern. Med. 2016. Vol. 33. P. 112-117.
Hsu P.F., Sung S.H., Cheng H.M. et al. Association of clinical symptomatic hypo-glycemia with
cardiovascular events and total mortality in type 2 diabetes: a nationwide population-based study //
Diabetes Care. 2013. Vol. 36, N. 4. P. 894-900.
Hsu T., Liu J., Hung S. et al. Renoprotectiveeffect of renin-angiotensin-aldosterone system blockade in
patients with predialysisadvanced chronic kidney disease, hypertension, and anemia // JAMA Intern.
Med. 2014. Vol. 174, N. 3. P. 347-354.
Hua C. et al. Effect of methotrexate, anti-tumor necrosis factor α, and rituximab on the immune
response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic
review and meta-analysis // Arthritis. Care. Res. 2014.
Vol. 66. P. 1016-1026.
Huang B., Huang Y., Li Y. et al. Adverse cardiovascular effects of concomitant use of proton pump
inhibitors and clopidogrel in patients with coronary artery disease: a systematic review and meta-
analysis // Arch. Med. Res. 2012. Vol. 43, N. 3. P. 212-224.
Huang E.S., Strate L.L., Ho W.W. et al. Long-term use of aspirin and the risk of
gastrointestinal bleeding // Am. J. Med. 2011. Vol. 124, N. 5. P. 426-433.
Huang E.S., Zhang Q., Gandra N. et al. The effect of comorbid illness and functional status on the
expected benefits of intensive glucose control in older patients with type 2 diabetes: adecision analysis
// Ann. Intern. Med. 2008. Vol. 149. P. 11-19.
Hughes L.D., McMurdo M.E.T., Guthrie B. Guidelines for people not for diseases: the challenges of
applying UK clinical guidelines to people with multimorbidity // Age
Ageing. 2013. Vol. 42, N. 1. P. 62-69.
Hum J., Jou J.H., Green P.K. et al. Improvement in glycemic control of type 2 diabetes after successful
treatment of hepatitis C virus // Diabetes Care. 2017. Vol. 40,
N. 9. P. 1173-1180.
Соседние файлы в папке Библиотека им академика М.И. Перельмана